ES493718A0 - Un procedimiento para la obtencion de agentes bloqueantes del receptor h2 de la histamina - Google Patents

Un procedimiento para la obtencion de agentes bloqueantes del receptor h2 de la histamina

Info

Publication number
ES493718A0
ES493718A0 ES493718A ES493718A ES493718A0 ES 493718 A0 ES493718 A0 ES 493718A0 ES 493718 A ES493718 A ES 493718A ES 493718 A ES493718 A ES 493718A ES 493718 A0 ES493718 A0 ES 493718A0
Authority
ES
Spain
Prior art keywords
histamine
procedure
obtaining
blocking agents
receptor blocking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES493718A
Other languages
English (en)
Other versions
ES8106715A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES493718A0 publication Critical patent/ES493718A0/es
Publication of ES8106715A1 publication Critical patent/ES8106715A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ES493718A 1978-12-18 1980-07-24 Un procedimiento para la obtencion de agentes bloqueantes del receptor h2 de la histamina Expired ES8106715A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/970,517 US4200578A (en) 1978-12-18 1978-12-18 Thiazole derivatives

Publications (2)

Publication Number Publication Date
ES493718A0 true ES493718A0 (es) 1981-09-01
ES8106715A1 ES8106715A1 (es) 1981-09-01

Family

ID=25517073

Family Applications (2)

Application Number Title Priority Date Filing Date
ES487035A Expired ES8101569A1 (es) 1978-12-18 1979-12-18 Un procedimiento para la obtencion de agentes bloqueantes dereceptor h2 de la histamina
ES493718A Expired ES8106715A1 (es) 1978-12-18 1980-07-24 Un procedimiento para la obtencion de agentes bloqueantes del receptor h2 de la histamina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES487035A Expired ES8101569A1 (es) 1978-12-18 1979-12-18 Un procedimiento para la obtencion de agentes bloqueantes dereceptor h2 de la histamina

Country Status (24)

Country Link
US (1) US4200578A (es)
JP (1) JPS5583768A (es)
KR (3) KR830001920B1 (es)
AT (1) AT375354B (es)
AU (1) AU533014B2 (es)
BE (1) BE880662A (es)
CA (1) CA1133909A (es)
CH (1) CH642956A5 (es)
DE (1) DE2950838A1 (es)
DK (1) DK533979A (es)
ES (2) ES8101569A1 (es)
FI (1) FI793904A (es)
FR (1) FR2444674B1 (es)
GB (1) GB2038822B (es)
GR (1) GR73586B (es)
HU (1) HU182461B (es)
IE (1) IE49320B1 (es)
IL (1) IL58960A (es)
IT (1) IT1164076B (es)
LU (1) LU82000A1 (es)
NL (1) NL7909054A (es)
SE (1) SE444680B (es)
YU (3) YU292179A (es)
ZA (1) ZA796814B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31588E (en) * 1977-06-03 1984-05-22 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
GR71929B (es) * 1979-11-13 1983-08-19 Ici Ltd
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
US4458077A (en) * 1982-11-22 1984-07-03 American Home Products Corporation Heterocyclic anti-ulcer agents
JPS59104370A (ja) * 1982-12-03 1984-06-16 Kotobuki Seiyaku Kk チアゾ−ル誘導体及びその製造方法
ES8601941A1 (es) * 1983-02-07 1985-11-01 Lilly Co Eli Un procedimiento para la preparacion de nizatidina
EP0230127A1 (en) * 1985-12-18 1987-07-29 Eli Lilly And Company Synthesis of nizatidine
JPH0247453U (es) * 1988-09-29 1990-03-30
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer
CN111974333B (zh) * 2020-08-19 2023-06-09 宁夏亚东化工有限公司 噻唑生产线及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US4072748A (en) * 1972-09-05 1978-02-07 Smith Kline & French Laboratories Limited Certain guanidine compounds, and their use as inhibitors of histamine activity
BE804144A (en) 1972-09-05 1974-02-28 Smith Kline French Lab H-2-Receptor antihistamines esp gastric acid inhibitors - -N-cyano-N"-(heterocyclyl-alkyl-(thio oxa amino or methylene-alkyl)-guanidines
GB1421792A (en) 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
GB1553070A (en) 1975-05-21 1979-09-19 Smith Kline French Lab Thiourea guanidine and 1-nitro-2,2-diaminoethylene derivatives
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4112234A (en) * 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines

Also Published As

Publication number Publication date
KR830001263A (ko) 1983-04-29
IT1164076B (it) 1987-04-08
JPS639512B2 (es) 1988-02-29
AT375354B (de) 1984-07-25
KR840004685A (ko) 1984-10-22
KR840004686A (ko) 1984-10-22
KR840001075B1 (ko) 1984-07-31
FR2444674B1 (fr) 1986-03-28
DE2950838A1 (de) 1980-07-03
ES487035A0 (es) 1980-12-16
ATA793779A (de) 1983-12-15
GB2038822A (en) 1980-07-30
IL58960A (en) 1983-06-15
BE880662A (fr) 1980-06-17
FR2444674A1 (fr) 1980-07-18
JPS5583768A (en) 1980-06-24
GR73586B (es) 1984-03-26
DK533979A (da) 1980-06-19
ZA796814B (en) 1980-11-26
YU259382A (en) 1983-02-28
CA1133909A (en) 1982-10-19
ES8101569A1 (es) 1980-12-16
KR840001074B1 (ko) 1984-07-31
AU533014B2 (en) 1983-10-27
LU82000A1 (de) 1980-07-21
YU292179A (en) 1983-02-28
YU259482A (en) 1983-02-28
IT7950977A0 (it) 1979-12-04
GB2038822B (en) 1983-01-19
HU182461B (en) 1984-01-30
SE7910392L (sv) 1980-06-19
FI793904A (fi) 1980-06-19
NL7909054A (nl) 1980-06-20
IE792436L (en) 1980-06-18
KR830001920B1 (ko) 1983-09-23
SE444680B (sv) 1986-04-28
US4200578A (en) 1980-04-29
IE49320B1 (en) 1985-09-18
IL58960A0 (en) 1980-03-31
CH642956A5 (fr) 1984-05-15
ES8106715A1 (es) 1981-09-01
AU5371679A (en) 1980-06-26

Similar Documents

Publication Publication Date Title
AR218326A1 (es) Un procedimiento para la fabricacion de derivados de 1,1,2-trifenilalqueno
ES496889A0 (es) Un procedimiento para la preparacion de derivados del indol
ES484980A0 (es) Un procedimiento para la preparacion de un indol
ES494300A0 (es) Un procedimiento para la preparacion de carboxialquil-dipep-tidos
ES493718A0 (es) Un procedimiento para la obtencion de agentes bloqueantes del receptor h2 de la histamina
ES479988A0 (es) Un procedimiento para la preparacion de nuevos derivados - hete rociclicos.
AR210802A1 (es) Un procedimiento para la preparacion del nuevo 5-pridoxalfosfato de vincamina
AR225794A1 (es) Un procedimiento para la preparacion de 2-(2-(1,4-benzodioxanil))-2-imidazolina
ES504121A0 (es) Un procedimiento para la preparacion de imidazoles antiinflamaticos.
ES474764A0 (es) Un procedimiento para la preparacion de ftalazinas.
ES490213A0 (es) Un procedimiento para la preparacion de fenetanolaminas
AR213555A1 (es) Procedimiento para la preparacion de 2,5-diclorofenol
AR222511A1 (es) Un procedimiento para la preparacion de 11-acetil-4"-deoxi-4"-furfurilamino-oleandomicina"
OA05595A (fr) Procédé de préparation d'un antagoniste d'histamine H2.
ES493202A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ZA783141B (en) Histamine h2 receptor antagonists
AR219321A1 (es) Procedimiento para la fabricacion de un recipiente
ES480121A0 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina.
ES505433A0 (es) Un procedimiento para la preparacion de nuevos imidazoles.
AR222147A1 (es) Un procedimiento para la preparacion de compuestos de 4"-deixo-4"-amino-eritromicina"a"
AR210207A1 (es) Un procedimiento para la preparacion de nuevas nicotinoilamino triacinas
ES520982A0 (es) Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina.
IT1098369B (it) Procedimento per la preparazione di un ciclopentendione
ES493200A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES478772A0 (es) Un procedimiento para la preparacion de quinazolinas.